Imaging phenotypes predict overall survival in glioma more accurate than basic demographic and cell mutation profiles
Authors: 
Saima Rathore, Muhammad A. Iftikhar, Ahmad Chaddad, Ashish Singh, Zeeshan Gillani, Ahmed AbdulkadirAuthors Info & Claims
References
[1]
A.N. Mamelak, D.B. Jacoby, Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601), Expert Opin. Drug Deliv. 4 (2007) 175–186.
[2]
M.L. Goodenberger, R.B. Jenkins, Genetics of adult glioma, Cancer Genet. 205 (2012) 613–621.
[3]
R. Stupp, et al., Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial, JAMA 318 (2017) 2306–2316.
[4]
R. Stupp, et al., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol. 10 (2009) 459–466.
[5]
M.R. Gilbert, et al., A randomized trial of bevacizumab for newly diagnosed glioblastoma, N. Engl. J. Med. 370 (2014) 699–708.
[6]
S. Rathore, et al., Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1, Sci. Rep. 8 (2018) 5087.
[7]
L. Macyszyn, et al., Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques, Neuro. Oncol. 18 (2016) 417–425.
[8]
S. Bae, et al., Radiomic MRI phenotyping of glioblastoma: improving survival prediction, Radiology 289 (2018) 797–806.
[9]
P. Kickingereder, et al., Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models, Radiology 280 (2016) 880–889.
[10]
M.A. Iftikhar, S. Rathore, M. Nasrallah, Analysis of microscopic images via deep neural networks can predict outcome and IDH and 1p/19q codeletion status in gliomas, J. Neuropathol. Exp. Neurol. 78 (2019) 553.
[11]
P. Mobadersany, et al., Predicting cancer outcomes from histology and genomics using convolutional networks, Proc. Natl. Acad. Sci. U.S.A. 115 (2018) E2970–E2979.
[12]
G. Shukla, et al., Radiomic features from multi-institutional glioblastoma MRI offer additive prognostic value to clinical and genomic markers, in: Focus on TCGA-GBM Collection. ASTRO's 59th Annual Meeting - American Society for Radiation Oncology , 2017, submitted.
[13]
A. Chaddad, P. Daniel, C. Desrosiers, M. Toews, B. Abdulkarim, Novel radiomic features based on joint intensity matrices for predicting glioblastoma patient survival time, IEEE J. Biomed. Health Inform. 23 (2019) 795–804.
[14]
A. Chaddad, P. Daniel, S. Sabri, C. Desrosiers, B. Abdulkarim, Integration of radiomic and multi-omic analyses predicts survival of newly diagnosed IDH1 wild-type glioblastoma, Cancers 11 (2019).
[15]
T.A. Juratli, et al., IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas, J. Neurooncol. 108 (2012) 403–410.
[16]
Q. SongTao, et al., IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma, Cancer Sci. 103 (2012) 269–273.
[17]
G. Shen, et al., The MRI features and prognosis of gliomas associated with IDH1 mutation: a single center study in southwest China, Front. Oncol. 10 (2020) 852.
[18]
J. Lipkova, et al., Artificial intelligence for multimodal data integration in oncology, Cancer Cell 40 (2022) 1095–1110.
[19]
K.M. Boehm, P. Khosravi, R. Vanguri, J. Gao, S.P. Shah, Harnessing multimodal data integration to advance precision oncology, Nat. Rev. Cancer 22 (2022) 114–126.
[20]
S. Rathore, A. Chaddad, M.A. Iftikhar, M. Bilello, A. Abdulkadir, Combining MRI and histologic imaging features for predicting overall survival in patients with glioma, Radiology 3 (2021).
[21]
N. Beig, et al., Radiogenomic-based survival risk stratification of tumor habitat on Gd-T1w MRI is associated with biological processes in glioblastoma, Clinic. Cancer Res. (2020) clincanres.2556.2019.
[22]
Y. Cui, et al., prognostic imaging biomarkers in glioblastoma: development and independent validation on the basis of multiregion and quantitative analysis of MR images, Radiology 278 (2016) 546–553.
[23]
S.M. Smith, J.M. Brady, SUSAN—A new approach to low level image processing, Int. J. Comput. Vis. 23 (1997) 45–78.
[24]
N.J. Tustison, et al., N4ITK: improved N3 Bias Correction, IEEE Trans. Med. Imaging 29 (2010) 1310–1320.
[25]
M. Jenkinson, S. Smith, A global optimisation method for robust affine registration of brain images, Med. Image Anal. 5 (2001) 143–156.
[26]
M. Jenkinson, M. Pechaud, S. Smith, Eleventh Annual Meeting of the Organization for Human Brain Mapping, 2005.
[27]
R.T. Shinohara, et al., Statistical normalization techniques for magnetic resonance imaging, Neuroimage Clin. 6 (2014) 9–19.
[28]
D. Kwon, et al., PORTR: pre-operative and post-recurrence brain tumor registration, IEEE Trans. Med. Imaging 33 (2014) 651–667.
[29]
M.M. Galloway, Texture analysis using grey level run lengths, Comput. Graph. Image Process. 4 (1975) 172–179.
[30]
X. Tang, Texture information in run-length matrices, IEEE Trans. Image Process. 7 (1998) 1602–1609.
[31]
M. Amadasun, R. King, Textural features corresponding to textural properties, IEEE Trans. Syst. Man Cybern. 19 (1989) 1264–1274.
[32]
R.M. Haralick, K. Shanmugam, I.H. Dinstein, Textural features for image classification, IEEE Trans. Syst. Man Cybern. 3 (1973) 610–621.
[33]
K. Robinson, P.F. Whelan, Efficient morphological reconstruction: a downhill filter, Pattern Recognit. Lett. 25 (2004) 1759–1767.
[34]
J. Roerdink, A. Meijster, The watershed transform: definitions, algorithms, and parallelization strategies, Fundam. Inform. 41 (2000) 187–228.
[35]
S. Rathore, M.A. Iftikhar, M. Hussain, A. Jalil, IEEE 9th International Conference on Emerging Technologies (ICET), 2013, IEEE, 2013, pp. 1–6.
[36]
S. Rathore, A. Iftikhar, A. Ali, M. Hussain, A. Jalil, International Multi Topic Conference, Springer, Berlin, Heidelberg, 2012, pp. 373–384.
[37]
L. Macyszyn, et al., Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques, Neuro-oncology 18 (2015) 417–425.
[38]
S. Rathore, et al., Medical Imaging 2018: Computer-Aided Diagnosis, International Society for Optics and Photonics, 2018, vol. 10575.
[39]
M. Law, et al., Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging, Radiology 247 (2008) 490–498.
[40]
D.A. Gutman, et al., MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set, Radiology 267 (2013) 560–569.
[41]
M.A. Mazurowski, A. Desjardins, J.M. Malof, Imaging descriptors improve the predictive power of survival models for glioblastoma patients, Neuro. Oncol. 15 (2013) 1389–1394.
[42]
S. Rathore, et al., Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1, Sci. Rep. 8 (2018) 1–12.
[43]
H. Itakura, et al., Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities, Sci. Transl. Med. 7 (2015) 303ra138.
[44]
J.K. Park, et al., Scale to predict survival after surgery for recurrent glioblastoma multiforme, J. Clin. Oncol. 28 (2010) 3838–3843.
[45]
P.O. Zinn, et al., A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature, PLoS One 7 (2012) e41522.
[46]
A. Chaddad, et al., Deep radiomic signature with immune cell markers predicts the survival of glioma patients, Neurocomputing (2021).
[47]
W.B. Pope, et al., Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study, J. Neurooncol. 108 (2012) 491–498.
[48]
Z. Zhang, et al., Identifying the survival subtypes of glioblastoma by quantitative volumetric analysis of MRI, J. Neurooncol. 119 (2014) 207–214.
[49]
J. Kalpathy-Cramer, E.R. Gerstner, K.E. Emblem, O. Andronesi, B. Rosen, Advanced magnetic resonance imaging of the physical processes in human glioblastoma, Cancer Res. 74 (2014) 4622–4637.
[50]
D.A. Lim, et al., Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype, Neuro. Oncol. 9 (2007) 424–429.
[51]
N.F. Jafri, J.L. Clarke, V. Weinberg, I.J. Barani, S. Cha, Relationship of glioblastoma multiforme to the subventricular zone is associated with survival, Neuro. Oncol. 15 (2013) 91–96.
[52]
K.L. Chaichana, et al., Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection, J. Neurooncol. 89 (2008) 219–224.
[53]
L. Hussain, W. Aziz, S. Saeed, S. Rathore, M. Rafique, 2018 17th IEEE International Conference On Trust, Security And Privacy In Computing And Communications/12th IEEE International Conference On Big Data Science And Engineering (TrustCom/BigDataSE), IEEE, 2018, pp. 327–331.
[54]
L. Hussain, et al., Prostate cancer detection using machine learning techniques by employing combination of features extracting strategies, Cancer Biomarkers 21 (2018) 393–413.
[55]
S. Rathore, M. Hussain, M.A. Iftikhar, A. Jalil, Ensemble classification of colon biopsy images based on information rich hybrid features, Comput. Biol. Med. 47 (2014) 76–92.
Recommendations
Glioma Segmentation and a Simple Accurate Model for Overall Survival Prediction
Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain InjuriesAbstractBrain tumor segmentation is a challenging task necessary for quantitative tumor analysis and diagnosis. We apply a multi-scale convolutional neural network based on the DeepMedic to segment glioma subvolumes provided in the 2018 MICCAI Brain Tumor ...
Segmentation of Brain Tumor Tissues in HGG and LGG MR Images Using 3D U-net Convolutional Neural Network
The quantitative assessment of tumor extent is necessary for surgical planning, as well as monitoring of tumor growth or shrinkage, and radiotherapy planning. For brain tumors, magnetic resonance imaging MRI is used as a standard for diagnosis and ...
Deep Learning Radiomics Algorithm for Gliomas (DRAG) Model: A Novel Approach Using 3D UNET Based Deep Convolutional Neural Network for Predicting Survival in Gliomas
Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain InjuriesAbstractAutomated segmentation of brain tumors in multi-channel Magnetic Resonance Image (MRI) is a challenging task. Heterogeneous appearance of brain tumors in MRI poses critical challenges in diagnosis, prognosis and survival prediction. In this paper,...
Comments
Please enable JavaScript to view thecomments powered by Disqus.Information & Contributors
Information
Published In
Copyright © 2023.
Publisher
Elsevier North-Holland, Inc.
United States
Publication History
Published: 01 February 2024
Author Tags
Qualifiers
- Research-article
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 0Total Downloads
- Downloads (Last 12 months)0
- Downloads (Last 6 weeks)0
Reflects downloads up to 12 Nov 2024
Other Metrics
Citations
View Options
View options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign in